Sars-Cov-2 Vaccination in Patients with Paroxysmal Nocturnal Hemoglobinuria: An Italian Multicenter Survey

SARS-CoV-2 infection and vaccination have raised concerns in paroxysmal nocturnal hemoglobinuria (PNH). In fact, PNH patients carry an increased infectious risk secondary to complement inhibition treatment or associated bone marrow failure (BMF), and may therefore benefit from preventive strategies...

Descripción completa

Detalles Bibliográficos
Autores principales: Giannotta, Juri Alessandro, Fattizzo, Bruno, Girmenia, Corrado, Ielo, Claudia, Metafuni, Elisabetta, Visentin, Adele, Bianchi, Paola, Apolito, Vincenzo, Beggiato, Eloise, Di Bona, Eros, Sica, Simona, Iori, Anna Paola, Barcellini, Wilma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
508.Bone Marrow Failure
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701642/
http://dx.doi.org/10.1182/blood-2021-150328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701642/
http://dx.doi.org/10.1182/blood-2021-150328

Ejemplares similares